Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Canadian Market Performance
7D7 Days: 0.9%
3M3 Months: 11.0%
1Y1 Year: 18.4%
YTDYear to Date: 10.4%
The market has been flat in the last week, however the Industrials sector is down 3.1%. More promisingly, the market is up 18% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.